Investing in AstraZeneca PLC (AZN)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)25.05-69
Intrinsic value (DCF)36.51-54
Graham-Dodd Method5.22-93
Graham Formula17.08-79

Company description

AZN is an innovative biopharmaceutical company that is dedicated to improving the health and well-being of people around the world. With a focus on research and development, the company strives to discover, develop, and market medications and therapies for a wide range of diseases and conditions. Their portfolio includes treatments for respiratory, cardiovascular, and rare diseases, as well as cancer, immunology, and neuroscience. With a presence in over 100 countries, AZN is committed to reaching patients in need everywhere through an extensive distribution network. Additionally, the company is dedicated to sustainability and community engagement, working to reduce their environmental impact and positively impact the communities in which they operate. With a strong commitment to innovation and improving the lives of patients, AZN continues to be a leader in the biopharmaceutical industry.